U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDSnews2025-07-23T19:13:21+00:00July 23rd, 2025|The New York Times|
A Pill for Sleep Apnea Could Be on the Horizonnews2025-07-23T16:50:42+00:00July 23rd, 2025|The New York Times|
AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threatnews2025-07-22T18:26:45+00:00July 22nd, 2025|The New York Times|
First Pill for Postpartum Depression Shows Varied Real-World Resultsnews2025-07-22T06:43:10+00:00July 22nd, 2025|The New York Times|
F.D.A. Panel Debates ‘Black Box’ Warning for Antidepressants in Pregnancynews2025-07-21T22:23:23+00:00July 21st, 2025|The New York Times|
Sarepta Refuses FDA Request to Stop Shipping Muscular Dystrophy Drug Elevidysnews2025-07-19T00:53:42+00:00July 19th, 2025|The New York Times|
Heath Insurers Are Denying More Drug Claims, Data Showsnews2025-07-18T18:46:44+00:00July 18th, 2025|The New York Times|
Trump Administration’s N.I.H. and F.D.A. Cuts Could Curtail New Drug Development, Budget Office Saysnews2025-07-18T16:08:45+00:00July 18th, 2025|The New York Times|
F.D.A. Panelists Call for Removal of Warnings on Menopause Treatmentsnews2025-07-17T21:48:42+00:00July 17th, 2025|The New York Times|
South African AIDS Activist Pushes for H.I.V. Treatment Access After U.S.-Aid Cutsnews2025-07-14T09:00:21+00:00July 14th, 2025|The New York Times|
